(Toronto, May 27, 2026) JMIR Publications today released a report on developments in the evidence gap in drug safety during pregnancy in its News and Perspectives section. In “ How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women ”, health writer Michelle Falci interviews the principal investigators of two projects which use machine learning to analyze large datasets of medication exposure and outcomes, then identify and evaluate possible links.
Pregnant Participants Excluded from Clinical Trials
Medical research has a serious problem with underrepresentation, Falci reports; only 4% of clinical trials over the last decade included pregnant women as participants. This trend dates back to 1977, when the US Food and Drug Administration recommended not to include pregnant women, or women capable of becoming pregnant, in phase 1 and 2 clinical trials, resulting in a gap in evidence on drug safety for pregnant women (and contributing to a broader underrepresentation of female participants in research). Though efforts have been made to determine medication safety for pregnant and breastfeeding women, these have fallen short in practice.
Closing the Gap with Machine Learning
Falci gets a closer look at two novel efforts to close this evidence gap: the BOOST-HP project, which uses a tree-based approach to data mining; and the BIONIC study, which combines causal inference and machine learning. Each approach uses machine learning to do the heavy lifting of analyzing large datasets, allowing the researchers to monitor and estimate the potential causal links.
However, this kind of AI-assisted research will ideally benefit from more data, according to BIONIC study leader Cristina Longo—plus, a healthy dose of caution. Transparency is key, as Almut G. Winterstein, a principal researcher on the BOOST-HP project, notes: she and her team use an AI model which allows them to trace the decision pathways leading to the models’ evaluations. If they were to use a ‘black box’ model—a system whose internal workings are opaque or obfuscated—they would run the risk of missing crucial epidemiological errors. Further thoughtful design of machine learning models, as well as a larger and more comprehensive dataset, nonetheless holds a great deal of promise for closing this evidence gap.
Please cite as:
Falci M. How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women. J Med Internet Res 2026;28:e101042
URL: https://www.jmir.org/2026/1/e101042
DOI: 10.2196/101042
About JMIR Publications News and Perspectives
JMIR Publications is a leading open access publisher of digital health research. The News and Perspectives section is the newest addition to its portfolio, established to bring the rigor and integrity of academic publishing to scientific journalism. The section features well-researched, expert-driven content from the Scientific News Editor, Kayleigh-Ann Clegg, PhD, and a network of specialist JMIR Publications Correspondents to keep the digital health community informed, inspired, and ahead of the curve.
About JMIR Publications
JMIR Publications is a leading open access publisher of digital health research and a champion of open science. With a focus on author advocacy and research amplification, JMIR Publications partners with researchers to advance their careers and maximize the impact of their work. As a technology organization with publishing at its core, we provide innovative tools and resources that go beyond traditional publishing, supporting researchers at every step of the dissemination process. Our portfolio features a range of peer-reviewed journals, including the renowned Journal of Medical Internet Research.
To find out more about JMIR Publications, visit jmirpublications.com or connect with them on Bluesky , X , LinkedIn , YouTube , Facebook , and Instagram .
Media Contact:
Dennis O’Brien, Vice President, Communications & Partnerships
JMIR Publications
communications@jmir.org
+1 416-583-2040
The content of this communication is licensed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
Journal of Medical Internet Research
Commentary/editorial
People
How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women
27-May-2026